Delivery Order SPE2DB22D3501-SPE2DB25FWQ99
- Not listed
- The Defense Logistics Agency awarded a $5,036.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count package) with completion targeted for September 4, 2025. This non-set-aside contract, issued on September 3, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly prescribed anti-nausea medication used across military healthcare systems to manage chemotherapy-induced...
- The Defense Logistics Agency awarded a $2,232.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, non-set-aside contract calls for performance at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.80 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea...
- The Defense Logistics Agency awarded a $1,763.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $8,691.62 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,770.55 for Ondansetron ODT 8 mg tablets (30-count packages) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed price contract represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is a widely used anti-nausea medication commonly stocked in military and federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) under a firm fixed-price contract valued at $26,561.64. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location....
- The Defense Logistics Agency awarded a $10,330.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This contract represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package, with a ceiling value of $4,539.09 and a completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. Ondansetron is an antiemetic...
- The Defense Logistics Agency awarded a $7,910.13 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication prescribed to prevent nausea and vomiting,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWQ99Delivery Order
The Defense Logistics Agency (DLA) awarded a $3,099.83 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets in quantities of 30 units, with an ultimate completion date of July 31, 2025. This non-set-aside contract was competitively awarded on July 30, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare settings to manage chemotherapy-induced nausea and postoperative nausea and vomiting. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's significant federal footprint reflects its role as a critical pharmaceutical distributor for Department of Defense medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/30/25 |